Key Takeaways
- Quantum Computing (QUBT) releases Q4 FY25 earnings results on March 2, 2026
- Analysts project a $0.02 per share loss, significantly improved from the $0.47 loss reported last year
- Expected revenue of $390K represents a substantial increase from $62K in the prior-year quarter
- Shares declined 8.4% on February 27, now trading beneath key 50-day and 200-day moving averages
- Options market implies a potential 14.05% price swing following the earnings announcement
Quantum Computing Inc. prepares to unveil its Q4 FY25 financial results this Monday, March 2, 2026. Share performance has been challenging recently, with the stock closing at $8.278 on February 27 after an 8.4% decline.
Session volume reached approximately 3.37 million shares — representing a dramatic 78% decrease compared to its typical 15 million share average. Such light-volume selloffs may indicate weak market participation, though they rarely paint the complete picture.
The shares currently trade beneath both the 50-day moving average at $10.35 and the 200-day moving average at $13.70. Despite recent pressure, QUBT maintains a gain exceeding 39% over the trailing twelve months, fueled primarily by enthusiasm surrounding its photonic computing capabilities.
Street consensus calls for a $0.02 per share loss in Q4 2025. This represents substantial progress compared to the $0.47 per share deficit recorded during the corresponding period last year.
Revenue projections stand at $390K, a notable increase from the $62K generated in Q4 2024. Though absolute figures remain modest, the growth trajectory is capturing analyst attention.
Luminar Deal Takes Center Stage
A major narrative surrounding the upcoming earnings call centers on the company’s $110 million all-cash purchase of Luminar Semiconductor Inc., formerly part of Luminar Technologies. This strategic acquisition aims to strengthen QUBT’s technology infrastructure and accelerate its path toward consistent revenue generation.
Market participants will be closely monitoring management commentary regarding semiconductor production schedules, fulfillment of existing orders, and any preliminary indicators of revenue acceleration stemming from the transaction.
Price Targets See Downward Revisions
Wall Street opinion remains divided. Lake Street analyst Max Michaelis maintained his Buy recommendation while reducing his price objective from $24 to $16 — still suggesting approximately 77% potential appreciation from current trading levels.
Ascendiant Capital Markets similarly adjusted its target downward from $40 to $25 while preserving its Buy stance. Taking a more reserved approach, Wedbush launched coverage with a Neutral rating and $12 target, while Cantor Fitzgerald reaffirmed its Neutral position with a $15 price objective.
Rosenblatt Securities initiated coverage this January with a Buy rating and $22 target. The consensus rating lands at Moderate Buy, comprising one Strong Buy, two Buys, two Holds, and one Sell among covering analysts.
The mean price target across all analysts stands at $18.00, implying roughly 99% upside potential from the February 27 closing price.
QUBT exhibits a beta coefficient of 3.44, indicating substantial volatility relative to broader market movements. The company’s market capitalization stands at approximately $1.83 billion, with a negative P/E ratio of -13.40 reflecting its current pre-profitable state.
Company insiders control 19.3% of outstanding shares. COO Milan Begliarbekov divested 2,860 shares on January 7 at $11.85 per share, trimming his holdings by approximately 10.55%. Institutional investors maintain a modest 4.26% ownership stake.
Derivatives traders are anticipating approximately a 14.05% move in either direction when earnings results are announced.
Q4 FY25 financial results will be released before market open on March 2, 2026.





